Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $766.3000 (0.17%) ($766.3000 - $766.3000) on Thu. Dec. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.69% (three month average) | RSI | 63 | Latest Price | $766.3000(0.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) DIA(34%) IWD(30%) SPLV(30%) IVW(29%) | Factors Impacting REGN price | REGN will decline at least -0.845% in a week (0% probabilities). TBT(-16%) URA(-3%) UUP(-2%) ARKG(-2%) VCSH(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.845% (StdDev 1.69%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $760.03(0.82%) | 10 Day Moving Average | $752.87(1.78%) | 20 Day Moving Average | $745.97(2.73%) | To recent high | 0% | To recent low | 11.9% | Market Cap | $81.25b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |